TGFB2 and breast cancer: Five genes exhibited HRs greater than 1.3 (30% increase in hazard for one standard deviation unit (Zscore) increase in mRNA expression): ENO1, GLRX2, PLOD1, PRDX4, TMED9, and TAGLN2 showed an HR of 1.7, controlling for TGFB2 mRNA expression, chemotherapy treatment, age at diagnosis, and subtypes of breast cancer (Figure 7, Table 1).